Hemorrhagic telangiectasia with thrombocytopenia in a newborn infant

Pediatrics International

Volumn 42, Issue 6, 2000, Pages 693-695

  Urushihara, Maki ^a,b   Furukawa, Seikyo ^a   Ota, Akira ^a   Iwai, Asayuki ^a   Matsumura, Kayoko ^a   Hamada, Yoshinori ^a  

^a National Hospital Organization   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Angiodysplasia; Hereditary hemorrhagic telangiectasia; Newborn; Thrombocytopenia

Indexed keywords

ANTACID AGENT; CORTICOSTEROID; HEMOSTATIC AGENT;

ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; GESTATIONAL AGE; HISTOPATHOLOGY; HUMAN; LABORATORY DIAGNOSIS; LEUKOCYTE COUNT; NEWBORN; NEWBORN DISEASE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; SKIN BIOPSY; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ADRENAL CORTEX HORMONES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INFANT, NEWBORN; SKIN; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; THROMBOCYTOPENIA;

EID: 0034519603     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200X.2000.01296.x     Document Type: Article

References (6)

1. Hereditary hemorrhagic telangiectasia: A clinical analysis
2. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary hemorrhagic telangiectasia type 1
3. Mutations in the activin receptor-like kinase 1 gene in hereditary hemorrhagic telangiectasia type 2
4. Infantile hemorrhagic angiodysplasia
5. Vascular disorder
6. Hormone therapy for gastrointestinal bleeding in hereditary hemorrhagic telangiectasia